Dan A Dixon

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Binding Protein

Cancer Stem Cells

Top Venues

Molecular cancer therapeutics

Cancer research

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Luis A Arteaga-Blanco, Andrew E Evans, Dan A Dixon
Plasma-Derived Extracellular Vesicles and Non-Extracellular Vesicle Components from APC Min/+ Mice Promote Pro-Tumorigenic Activities and Activate Human Colonic Fibroblasts via the NF-κB Signaling Pathway. Cells 13 (14) (2024)
Luis A Arteaga-Blanco, Andrew E Evans, Dan A Dixon
Plasma-Derived Extracellular Vesicles and Non-Extracellular Vesicle Components from APC Min/+ Mice Promote Pro-Tumorigenic Activities and Activate Human Colonic Fibroblasts via the NF-κB Signaling Pathway. Cells 13 (14) (2024)
Luis A Arteaga-Blanco, Andrew E Evans, Dan A Dixon
Plasma-Derived Extracellular Vesicles and Non-Extracellular Vesicle Components from APC Min/+ Mice Promote Pro-Tumorigenic Activities and Activate Human Colonic Fibroblasts via the NF-κB Signaling Pathway. Cells 13 (14) (2024)
Jennifer M Finan, Thomas Lee Sutton, Dan A Dixon, Jonathan R Brody
Targeting the RNA-binding protein HuR in cancer. Cancer research (2023)
Samantha Z Brown, Grace A McCarthy, James R Carroll, Roberto Di Niro, Carl Pelz, Aditi Jain, Thomas L Sutton, Hannah D Holly, Avinoam Nevler, Christopher W Schultz, Matthew D McCoy, Joseph A Cozzitorto, Wei Jiang, Charles J Yeo, Dan A Dixon, Rosalie C Sears, Jonathan R Brody
The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Adenocarcinoma. Molecular and cellular biology 42 (7) (2022)
Christopher W Schultz, Grace A McCarthy, Teena Nerwal, Avinoam Nevler, James B DuHadaway, Matthew D McCoy, Wei Jiang, Samantha Z Brown, Austin Goetz, Aditi Jain, Valerie S Calvert, Vikalp Vishwakarma, Dezhen Wang, Ranjan Preet, Joel Cassel, Ross Summer, Hoora Shaghaghi, Yves Pommier, Simone A Baechler, Michael J Pishvaian, Talia Golan, Charles J Yeo, Emanuel F Petricoin, George C Prendergast, Joseph M Salvino, Pankaj K Singh, Dan A Dixon, Jonathan R Brody
The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria. Molecular cancer therapeutics 20 (11) (2021)
Ruochen Dong, Ping Chen, Kishore Polireddy, Xiaoqing Wu, Tao Wang, Remya Ramesh, Dan A Dixon, Liang Xu, Jeffrey Aube, Qi Chen
An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells. Molecular cancer therapeutics 19 (11) (2020)
Xiaoqing Wu, Gulhumay Gardashova, Lan Lan, Shuang Han, Cuncong Zhong, Rebecca T Marquez, Lanjing Wei, Spencer Wood, Sudeshna Roy, Ragul Gowthaman, John Karanicolas, Philip Gao, Dan A Dixon, Danny R Welch, Ling Li, Min Ji, Jeffrey Aube, Liang Xu
Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis. Communications biology 3 (1) (2020)
Christopher W Schultz, Ranjan Preet, Teena Dhir, Dan A Dixon, Jonathan R Brody
Understanding and targeting the disease-related RNA binding protein human antigen R (HuR). Wiley interdisciplinary reviews. RNA 11 (3) (2020)
Nicholas J Monteleone, Ashleigh E Moore, Joseph R Iacona, Carol S Lutz, Dan A Dixon
miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer. Scientific reports 9 (1) (2019)